These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 15128475)

  • 1. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.
    El-Atat F; McFarlane SI; Sowers JR
    Curr Hypertens Rep; 2004 Jun; 6(3):215-23. PubMed ID: 15128475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of obesity hypertension and diabetes syndrome.
    Zanella MT; Kohlmann O; Ribeiro AB
    Hypertension; 2001 Sep; 38(3 Pt 2):705-8. PubMed ID: 11566961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    Sowers JR; Frohlich ED
    Med Clin North Am; 2004 Jan; 88(1):63-82. PubMed ID: 14871051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood pressure, diabetes and diabetic nephropathy.
    Chantrel F; Moulin B; Hannedouche T
    Diabetes Metab; 2000 Jul; 26 Suppl 4():37-44. PubMed ID: 10922972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists in patients with type 2 diabetes and hypertension.
    McFarlane SI; Farag A; Sowers J
    Cardiovasc Drug Rev; 2003; 21(2):105-18. PubMed ID: 12847562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microalbuminuria, insulin resistance, diabetes, hypertension, and kidney function: the latest concepts in pathology and pharmacologic treatment.
    Barri YM; Palmer BF; Ram CV
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):34-45. PubMed ID: 19667709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertension in diabetes mellitus].
    Jermendy G
    Orv Hetil; 2009 Sep; 150(39):1813-23. PubMed ID: 19758961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension in diabetes: optimal pharmacotherapy.
    Biswas A; Alvarez A; Mukherjee D
    Cardiovasc Hematol Agents Med Chem; 2011 Apr; 9(2):95-105. PubMed ID: 21366515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperinsulinemia, insulin resistance, and hypertension.
    Bönner G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.
    Khan NA; McAlister FA; Rabkin SW; Padwal R; Feldman RD; Campbell NR; Leiter LA; Lewanczuk RZ; Schiffrin EL; Hill MD; Arnold M; Moe G; Campbell TS; Herbert C; Milot A; Stone JA; Burgess E; Hemmelgarn B; Jones C; Larochelle P; Ogilvie RI; Houlden R; Herman RJ; Hamet P; Fodor G; Carruthers G; Culleton B; Dechamplain J; Pylypchuk G; Logan AG; Gledhill N; Petrella R; Tobe S; Touyz RM;
    Can J Cardiol; 2006 May; 22(7):583-93. PubMed ID: 16755313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan is a promising cardiometabolic sartan due to its unique PPAR-gamma-inducing property.
    Yamagishi S; Takeuchi M
    Med Hypotheses; 2005; 64(3):476-8. PubMed ID: 15617852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy.
    Yan X; Li Y; Dong Y; Wu Y; Li J; Bian R; Hu D
    Lipids Health Dis; 2019 Jan; 18(1):32. PubMed ID: 30696435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy.
    Cziraky MJ; Mehra IV; Wilson MD; Bakris GL
    Ann Pharmacother; 1996; 30(7-8):791-801. PubMed ID: 8826564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy. An update.
    Sowers JR; Epstein M
    Hypertension; 1995 Dec; 26(6 Pt 1):869-79. PubMed ID: 7490142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current status of antihypertensive prescription and associated blood pressure control in Japan.
    Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
    Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When hypertension and diabetes coexist: strategies for cardiorenal protection.
    Weber MA
    Postgrad Med; 2000 Oct; 108(5 Suppl):12-8. PubMed ID: 19667536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.